Healing of Intrabony Defects Following Treatment With PRF or EMD

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 1, 2025

Study Completion Date

August 25, 2025

Conditions
Periodontal Bone LossPeriodontal DiseasePlatelet Rich Fibrin
Interventions
OTHER

Platelet rich fibrin

Platelet-rich fibrin (PRF) was prepared according to the manufacturer's instructions. A blood sample was collected from the cubital vein in 10 ml tubes without anticoagulant and centrifuged at 3000 rpm for 10 minutes using a GLO GT416 table centrifuge (GLO Glotech Co. Ltd, Korea) and GLO PRP collection kit (GLO PRP-Kit, Glotech Co, Asan Choong-nam, Korea/ Glofinn, Finland).

OTHER

Enamel matrix derivate

"In the control group, the root surface was conditioned with 24% ethylenediaminetetraacetic acid (EDTA) gel for two minutes, washed with physiological saline solution, dried, and treated with enamel matrix derivative (EMD), (Emdogain, Straumann, Switzerland) per manufacturer recommendations."

Trial Locations (1)

1088

Semmelweis University, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER

NCT07183631 - Healing of Intrabony Defects Following Treatment With PRF or EMD | Biotech Hunter | Biotech Hunter